Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas

Cancer Immunology, Immunotherapy

Volumn 53, Issue 9, 2004, Pages 835-839

  Banyai, Aniko ^a   Varga, Lilian ^b   Barta, Aniko ^a   Gopcsa, Laszlo ^a   Paloczi, Katalin ^b  

^a NATIONAL MEDICAL CENTER   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Autologous transplantation; Complement; Malignant lymphoma

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; INFECTION; LYMPHOMA; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

EID: 4344566730     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-004-0519-7     Document Type: Article

References (18)

1. Ahmed AE, Peter JB (1995) Clinical utility of complement assessment. Clin Diagn Lab Immunol 2(5):509-517
2. Apperly J, Bacigaluppo A, Friedrich W, Girínsky T (2000) Principles of conditioning regimens. In: Apperly J, Gluckman E, Gratwohl A (eds) The EBMT handbook 2000, revised edition: blood and marrow transplantation. ESH, Paris, pp 93-107
3. Arpaci F, Dogru T, Ozturk B, Komurcu S, Ozet A, Yilmaz MI, Beyzadeoglu M, Turan M, Sengul A, Yalcin A (2002) Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT). Haematologia 32(3):253-264
4. Banyai A, Paloczi K, Csipo I, Csongor I, Szegedi Gy (1990) Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma. Haematologia 23(2):87-95
5. Bierman PJ, Armitage JO (1998) Lymphoma. In: Reiffers J, Goldman JM, Armitage JO (eds) Blood stem cell transplantation. Martin Dunitz, London, pp 101-127
6. Hazelzet JA, de Groot R, van Mierlo G, Joosten KFM, van der Voort E, Eerenberg A, Suur MH, Hop WCJ, Hack CE (1998) Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect Immun 66(11):5350-5356
7. Johnson AJ, Mowbray JF, Porter KA (1975) Detection of circulating immune complexes in pathological human sera. Lancet 1:762-765
8. Kohler PF, Müller-Eberhard HJ (1967) Immunochemical quantitation of the third, fourth and fifth components of human complement: concentration in serum of healthy adult. J Immunol 99:1211-1216
9. Nilsson UR, Nilsson B (1984) Simplified assay of haemolytic activity of the classical and alternative complement pathway. J Immunol Methods 72:49-59
10. Paloczi K (2000) Immune reconstitution: an important component of a successful allogeneic transplantation. Immunol Letters 74:177-181
11. Platt JL, Saadi S (1999) The role of complement in transplantation. Mol Immunol 36(13-14):965-971
12. Salat C, Holler E, Schleuning M, Eisele B, Reinhardt B, Kolb H, Pihusch R, Domrath R, Hiller E (1995) Levels of the terminal complement complex, C3-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation. Ann Haematol 71(16):271-277
13. Salles G, Coiffier B (1999) Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. In: Gorin N-C (ed) Bailliere's clinical haematology. Harcourt, London, pp 151-169
14. Stöve S, Welte T, Wagner TO, Kola A, Klos A, Bautsch W, Köhl J (1996) Circulating complement component proteins in patients with sepsis or systemic inflammatory response syndrome. Clin Diagn Lab Immunol 3(2):175-183
15. Takatsuka H, Takemoto Y, Yamada S, Wada H, Tamura S, Fujumori Y, Okamoto T, Suehiro A, Kanamaru A, Kakishita E (2000) Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 26:419-426
16. Varga L, Poros A, Panya A, Kramer J, Gyodi E, Füst G (1995) Clinical significance of longitudinal complement measurements in recipient of bone marrow transplant. Bone Marrow Transplant 15:509-514
17. Witherspoon RP, Kopecky K, Storb RF, Flournoy N, Sullivan KM, Sosa R, Deeg HJ, Ochs HD, Cheever MA, Fefer A, Thomas ED (1982) Immunological recovery in 48 patients following syngeneic marrow transplantation for haematological malignancy. Transplantation 33:143-149
18. Yang YG, Chen AM, Sergio JJ, Zhou Y, Sykes M (2000) Role of antibody-independent complement activation in rejection of porcine bone marrow cells in mice. Transplantation 69(1):163-165